MBRX - Moleculin Biotech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 4/2/2020
Current
12/31/20199/30/20196/30/20193/31/2019
Market Cap (intraday) 5
30.63M41.85M50.76M56.49M27.85M
Enterprise Value 3
20.28M26.84M32.23M47.92M20.72M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.972.212.303.851.95
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-1.17-5.64-7.23-13.37-4.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.61
52-Week Change 3-43.59%
S&P500 52-Week Change 3-7.77%
52 Week High 33.1500
52 Week Low 30.3230
50-Day Moving Average 30.6204
200-Day Moving Average 30.9012

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 3700.35k
Shares Outstanding 553.23M
Float 37.89M
% Held by Insiders 112.99%
% Held by Institutions 123.12%
Shares Short (Mar 12, 2020) 4534.87k
Short Ratio (Mar 12, 2020) 40.9
Short % of Float (Mar 12, 2020) 41.95%
Short % of Shares Outstanding (Mar 12, 2020) 41.00%
Shares Short (prior month Feb 13, 2020) 41.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-48.87%
Return on Equity (ttm)-88.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.32M
Net Income Avi to Common (ttm)-13.21M
Diluted EPS (ttm)-0.3240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.73M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)379k
Total Debt/Equity (mrq)2.43
Current Ratio (mrq)3.78
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)-17.2M
Levered Free Cash Flow (ttm)-11.49M